ArticleInfectious diseases and therapy2021

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.

Konstantinos Tsiakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.